Sally I. Elsamanoudi

The paper identifies population-associated differences in chromatin regulation in prostate cancer, linking reduced CTCF accessibility to aggressive tumor biology in Black men.

This study identifies CRY1 as a stage-specific regulator of DNA damage repair in prostate cancer, showing it promotes NHEJ/BER in hormone-sensitive disease and HR in castration-resistant disease.

This study uses proteogenomics to identify ancestry-specific and shared molecular drivers in prostate cancer, revealing distinct biological programs and improving risk prediction.